Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04116489
Other study ID # H00016795
Secondary ID 1R21HD097771
Status Completed
Phase N/A
First received
Last updated
Start date July 5, 2019
Est. completion date December 31, 2022

Study information

Verified date May 2023
Source University of Massachusetts, Worcester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates a novel approach to animal-assisted interventions through a series of wildlife immersion activities (wildlife observation, wildlife rehabilitation and bird feeding/watching) for veterans who have suffered trauma as part of their military duty. Findings from this study will advance scientific knowledge about the benefits of wildlife activities for veterans with PTSD including the acceptability, feasibility, safety and preliminary influence on physical and mental well-being. The findings will be instrumental in advancing a new area of health intervention research for veterans in settings that are publicly accessible and family-oriented for sustainable, low-cost interventions with potential application in other populations.


Description:

This study utilized a crossover design. The intervention included an introductory forest walk followed by 3 wildlife immersion activity experiences in different settings that offered different ways to experience wildlife. This included an introductory forest walk, a wildlife rehabilitation center, a wildlife sanctuary and a bird watching program. Each activity was conducted twice to minimize potential anxiety and novelty effects. Activities were conducted in small groups to provide peer support.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Veterans with PTSD/PTSD symptoms (per self report) - Fully vaccinated against Covid-19, which is defined by the CDC as: - 2 weeks after second dose in a 2-dose series, such as the Pfizer or Moderna vaccines, or - 2 weeks after a single-dose vaccine, such as Johnson & Johnson's Janssen vaccine - Age 18-70 - Comfortable interacting with animals - Sufficient mobility to walk or navigate wheelchair up to one mile at leisurely pace - Cognitive ability to complete assessments - Service/ support animals are permitted as long as they meet the following criteria: the animal must be leashed, housebroken and with sufficient training that the owner has control over its barking and any other behaviors that would threaten the safety of other visitors or animals. - Participants with visual or hearing impairments must have corrected vision and hearing through glasses and/ or hearing aid(s). - No active addiction or intoxication as determined by 30 days or more free from drugs or alcohol abuse - Willing to refrain from alcohol and illicit substances before and during activities - No severe immunosuppression or other conditions with advisement by health care provider to limit or prevent contact with animals and birds - No severe outdoor allergy. - Not currently enrolled in the Veteran's Treatment Court program Exclusion Criteria: - Veterans without PTSD/PTSD symptoms (per self report - Not fully vaccinated against Covid-19 - Age <18 or >70 - Not comfortable interacting with animals - Not sufficiently mobile to walk or navigate wheelchair up to one mile at leisurely pace - Cognitively unable to complete assessments - Service/ support animals that do not meet the following criteria: leashed, housebroken and with sufficient training that the owner has control over its barking and any other behaviors that would threaten the safety of other visitors or animals. - Participants with visual or hearing impairments who do not have corrected vision and hearing through glasses and/ or hearing aid(s). - Active addiction or intoxication as determined by < 30 days free from drugs or alcohol abuse - Not willing to refrain from alcohol and illicit substances before and during activities - Severe immunosuppression or other conditions with advisement by health care provider to limit or prevent contact with animals and birds - Severe outdoor allergy - Currently enrolled in the Veteran's Treatment Court program

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Forest walk
Participants will be provided with an educational program about the forest and take a guided forest walk.
Wildlife rehabilitation
Participants will be provided with education on wildlife rehabilitation and assist with wildlife care such as feeding baby animals.
Wildlife sanctuary observation
Participants will be provided an educational program on wildlife care and accompany park game keepers during animal feeding and will observe iconic wildlife.
Bird feeding and watching
Participants will learn about bird identification and safe bird feeding. Bird feeders will be provided at the Soldier On facility for home bird feeding after study conclusion.

Locations

Country Name City State
United States University of Massachusetts Medical School Worcester Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
University of Massachusetts, Worcester Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of recruitment and retention of study participants Recruitment and retention of study participants will be measured in order to determine the feasibility of delivering a wildlife program to veterans with PTSD. Through study completion, approximately 12 weeks per participant
Primary Incidence of treatment-emergent adverse events Incidence will be measured through a safety log of adverse events. Through study completion, approximately 12 weeks per participant
Primary Acceptance of intervention to veterans with Post Traumatic Stress Disorder (PTSD) Participant acceptance of the intervention will be assessed through observation by PI during activities. Through study completion, approximately 12 weeks per participant
Primary Acceptance of intervention to veterans with Post Traumatic Stress Disorder (PTSD) through activity evaluation Participant acceptance of the intervention will be measured through activity evaluation forms at the end of each activity. Through study completion, approximately 12 weeks per participant
Primary Acceptance of intervention to veterans with Post Traumatic Stress Disorder (PTSD) through focus group feedback Participant acceptance of the intervention will be measured through focus groups following the last activity. Through study completion, approximately 12 weeks per participant
Primary Acceptance of intervention to veterans with Post Traumatic Stress Disorder (PTSD) Participant acceptance of the intervention will be assessed a follow up phone call with each participant approximately 4 weeks after study conclusion. 4 weeks after study conclusion
Primary Change in Post Traumatic Stress Disorder (PTSD) symptoms PTSD symptoms will be measured with the Posttraumatic Stress Disorder Checklist (PCL-5) which is a 20-item measure that assesses PTSD symptoms. Scores range from 0-80 with 33 or higher suggesting a provisional PTSD diagnosis. Baseline to study conclusion (approximately 12 weeks per participant).
Primary Change in perception of well being Perception of well being will be measured with the Warwick Edinburgh Mental Well Being Scale which is a 14 item instrument with scores ranging from 14 to 70. Higher scores indicate higher perceived well being. Baseline to study conclusion (approximately 12 weeks per participant).
Primary Change in anxiety Participant anxiety will be measured by the Spielberger State-Trait Anxiety Inventory (short form), a 6-item measure. The total score range is 20-80 with a higher score indicating higher anxiety. Baseline to study conclusion (approximately 12 weeks per participant).
Primary Change in depression Participant depression will be measured by the Center for the Epidemiological Study of Depression short form (CES-D-10) a 10 item instrument with a score range of 0-30 with higher scores indicating higher level of depression Baseline to study conclusion (approximately 12 weeks per participant).
Primary Change in participant stress based on salivary cortisol levels Participant stress will be measured via salivary cortisol levels. Normal ranges are:8-10 AM - 0.04-0.56 mcg/dL; Noon-2 PM - =0.21 mcg/dL; 4-6 PM - =0.15 mcg/dL; 10 PM-1 AM. Higher levels generally indicate higher stress although awakening cortisol can be reduced in chronic stress.
=0.09 mcg/dL
Baseline through study conclusion (approximately 12 weeks per participant).
Primary Change in participant stress based on heart rate Participant stress will be measured by heart rate via wearable wrist sensor Baseline through study conclusion (approximately 12 weeks per participant).
Secondary Change in relation to nature Connection to nature will be measured by the Nature Relatedness scale (short form) a 6-item scale. Scores range from 1-6 with a higher score indicating a stronger relationship to nature. Baseline to study conclusion (approximately 12 weeks per participant).
Secondary Change in feelings of valuation toward wildlife base on Transcendent Feelings of Animal Valuation Feelings of valuation toward wildlife will be measured by the Transcendent Feelings of Animal Valuation scale a 7-item instrument with scores ranging from 7-35 with higher scores indicating more positive feelings of valuation toward wildlife. Baseline to study conclusion (approximately 12 weeks per participant).
Secondary Change in connection with wildlife based on observation journal Connection with wildlife will be measured through a wildlife observation/ journal exercise with open ended questions After activities 5 and 6 at Maine Wildlife Park (up to 2-3 weeks per participant).
Secondary Change in connection with wildlife based on optional study extension journal activity Connection with wildlife will be assessed through an optional study extension journal activity 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05620381 - Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018
Completed NCT02856412 - Improving Mind/Body Health and Functioning With Integrative Exercise N/A
Recruiting NCT05400200 - PTSD and Self-regulation: Coping, Emotional Regulation and Cognitive Control and Their Relationships to Symptom Management N/A
Not yet recruiting NCT06088303 - Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication N/A
Not yet recruiting NCT03652922 - Propranolol Reactivation Mismatch (PRM) Treatment for PTSD Phase 4
Completed NCT02875912 - Prospective Evaluation of Family Care Rituals in the ICU N/A
Completed NCT01589575 - Anxiety and Depression in Relatives of Critically Ill Patients: Spouses Versus Other Close Relatives N/A
Completed NCT00990106 - Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD) N/A
Completed NCT01291368 - Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care N/A
Active, not recruiting NCT00657787 - Development of a Post-Traumatic Stress Disorder (PTSD) Population Registry for Veterans
Completed NCT00880152 - Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study N/A
Completed NCT00835627 - Treatment Trial for Psychogenic Nonepileptic Seizures Phase 4
Completed NCT01365247 - Concurrent Treatment for Substance Dependent Individuals With Post-Traumatic Stress Disorder (PTSD) N/A
Completed NCT00514956 - Effect of Emotional Freedom Technique and Diaphragmatic Breathing on Post Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT00419029 - Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment N/A
Completed NCT00333710 - Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD N/A
Completed NCT01120847 - Post Traumatic Stress Disorder (PTSD), Sleep Disordered Breathing And Genetics: Effects On Cognition
Completed NCT00069225 - Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder N/A
Completed NCT00055354 - Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD) N/A
Completed NCT00186212 - Alternative Support for Rural and Isolated Women in an HMO Phase 3